Loading…

Association between fasting glucose and C-reactive protein in middle-aged subjects

Aims  C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase r...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 2004-01, Vol.21 (1), p.39-44
Main Authors: Aronson, D., Bartha, P., Zinder, O., Kerner, A., Shitman, E., Markiewicz, W., Brook, G. J., Levy, Y.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563
cites cdi_FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563
container_end_page 44
container_issue 1
container_start_page 39
container_title Diabetic medicine
container_volume 21
creator Aronson, D.
Bartha, P.
Zinder, O.
Kerner, A.
Shitman, E.
Markiewicz, W.
Brook, G. J.
Levy, Y.
description Aims  C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects. Methods  We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years). Results  Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend 
doi_str_mv 10.1046/j.1464-5491.2003.01084.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80083950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80083950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563</originalsourceid><addsrcrecordid>eNqNkM1u1DAUhS0EokPLKyBvYJdw_Zt4waIaSosoRar6I7GxHOd65CGTtHFCp29PwozabSVLtuTv-B5_hFAGOQOpP69zJrXMlDQs5wAiBwalzLevyOLp4jVZQCF5JqBgB-RdSmsAxo0wb8kBkwVoUHxBLo9T6nx0Q-xaWuHwgNjS4NIQ2xVdNaPvElLX1nSZ9ej8EP8iveu7AWNLp7WJdd1g5lZY0zRWa_RDOiJvgmsSvt_vh-T628nV8iw7_3X6fXl8nnlpjMxYFUxQqIJmJlRYVmWhHRghkTtpvBdYMlELHaZfeMH8hHCt0HE0pTFKi0Pyaffu1Od-xDTYTUwem8a12I3JlgClMAomsNyBvu9S6jHYuz5uXP9oGdjZp13bWZudtdnZp_3v026n6If9jLHaYP0c3AucgI97wCXvmtC71sf0zCnFOYO57Jcd9xAbfHxxAfv158l8mvLZLh_TgNunvOv_WF2IQtnbi1Or2fL3zY8zbrn4B3-7n7Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80083950</pqid></control><display><type>article</type><title>Association between fasting glucose and C-reactive protein in middle-aged subjects</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Aronson, D. ; Bartha, P. ; Zinder, O. ; Kerner, A. ; Shitman, E. ; Markiewicz, W. ; Brook, G. J. ; Levy, Y.</creator><creatorcontrib>Aronson, D. ; Bartha, P. ; Zinder, O. ; Kerner, A. ; Shitman, E. ; Markiewicz, W. ; Brook, G. J. ; Levy, Y.</creatorcontrib><description>Aims  C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects. Methods  We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years). Results  Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend &lt; 0.0001). Increasing CRP with higher fasting glucose levels was apparent even among subjects with fasting glucose in the normal range (Ptrend = 0.039), and subjects with fasting glucose level in the upper quartile of normal fasting glucose had higher CRP levels compared with subjects in the lower quartile (P = 0.035). There was a positive crude correlation between CRP and smoking, post‐menopausal hormone use, body mass index, fasting glucose, triglycerides, hypertension, and uric acid (r = 0.11–0.36, P = 0.002–0.0001). A negative correlation was found between CRP and HDL‐cholesterol (r = 0.12, P &lt; 0.0001) and physical activity (r = 0.11, P = 0.002). After adjustment for potential confounders in a stepwise multivariate linear regression model, fasting glucose remained significantly and independently related to CRP levels (correlation coefficient 0.06; 95% confidence interval 0.014–0.11, P = 0.011). Conclusions  Fasting glucose is significantly and positively associated with plasma CRP in middle‐aged subjects. CRP levels increase continuously across the spectrum of fasting glucose, beginning in the lowest quartile of normal fasting glucose. This finding suggests that a proinflammatory effect may contribute to the adverse cardiovascular outcome associated with diabetes, impaired fasting glucose, and increasing glucose levels within the normal range.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1046/j.1464-5491.2003.01084.x</identifier><identifier>PMID: 14706052</identifier><identifier>CODEN: DIMEEV</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Biological and medical sciences ; Blood Glucose - analysis ; Body Mass Index ; C-reactive protein ; C-Reactive Protein - analysis ; Cholesterol, HDL - blood ; Cross-Sectional Studies ; Diabetes Mellitus - blood ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Fasting - blood ; Female ; glucose ; Hormone Replacement Therapy ; Humans ; inflammation ; insulin resistance syndrome ; Male ; Medical sciences ; Metabolic Syndrome - blood ; Middle Aged ; obesity ; Smoking ; Uric Acid - blood</subject><ispartof>Diabetic medicine, 2004-01, Vol.21 (1), p.39-44</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563</citedby><cites>FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15522106$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14706052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aronson, D.</creatorcontrib><creatorcontrib>Bartha, P.</creatorcontrib><creatorcontrib>Zinder, O.</creatorcontrib><creatorcontrib>Kerner, A.</creatorcontrib><creatorcontrib>Shitman, E.</creatorcontrib><creatorcontrib>Markiewicz, W.</creatorcontrib><creatorcontrib>Brook, G. J.</creatorcontrib><creatorcontrib>Levy, Y.</creatorcontrib><title>Association between fasting glucose and C-reactive protein in middle-aged subjects</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Aims  C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects. Methods  We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years). Results  Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend &lt; 0.0001). Increasing CRP with higher fasting glucose levels was apparent even among subjects with fasting glucose in the normal range (Ptrend = 0.039), and subjects with fasting glucose level in the upper quartile of normal fasting glucose had higher CRP levels compared with subjects in the lower quartile (P = 0.035). There was a positive crude correlation between CRP and smoking, post‐menopausal hormone use, body mass index, fasting glucose, triglycerides, hypertension, and uric acid (r = 0.11–0.36, P = 0.002–0.0001). A negative correlation was found between CRP and HDL‐cholesterol (r = 0.12, P &lt; 0.0001) and physical activity (r = 0.11, P = 0.002). After adjustment for potential confounders in a stepwise multivariate linear regression model, fasting glucose remained significantly and independently related to CRP levels (correlation coefficient 0.06; 95% confidence interval 0.014–0.11, P = 0.011). Conclusions  Fasting glucose is significantly and positively associated with plasma CRP in middle‐aged subjects. CRP levels increase continuously across the spectrum of fasting glucose, beginning in the lowest quartile of normal fasting glucose. This finding suggests that a proinflammatory effect may contribute to the adverse cardiovascular outcome associated with diabetes, impaired fasting glucose, and increasing glucose levels within the normal range.</description><subject>Biological and medical sciences</subject><subject>Blood Glucose - analysis</subject><subject>Body Mass Index</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - analysis</subject><subject>Cholesterol, HDL - blood</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Fasting - blood</subject><subject>Female</subject><subject>glucose</subject><subject>Hormone Replacement Therapy</subject><subject>Humans</subject><subject>inflammation</subject><subject>insulin resistance syndrome</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Syndrome - blood</subject><subject>Middle Aged</subject><subject>obesity</subject><subject>Smoking</subject><subject>Uric Acid - blood</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNkM1u1DAUhS0EokPLKyBvYJdw_Zt4waIaSosoRar6I7GxHOd65CGTtHFCp29PwozabSVLtuTv-B5_hFAGOQOpP69zJrXMlDQs5wAiBwalzLevyOLp4jVZQCF5JqBgB-RdSmsAxo0wb8kBkwVoUHxBLo9T6nx0Q-xaWuHwgNjS4NIQ2xVdNaPvElLX1nSZ9ej8EP8iveu7AWNLp7WJdd1g5lZY0zRWa_RDOiJvgmsSvt_vh-T628nV8iw7_3X6fXl8nnlpjMxYFUxQqIJmJlRYVmWhHRghkTtpvBdYMlELHaZfeMH8hHCt0HE0pTFKi0Pyaffu1Od-xDTYTUwem8a12I3JlgClMAomsNyBvu9S6jHYuz5uXP9oGdjZp13bWZudtdnZp_3v026n6If9jLHaYP0c3AucgI97wCXvmtC71sf0zCnFOYO57Jcd9xAbfHxxAfv158l8mvLZLh_TgNunvOv_WF2IQtnbi1Or2fL3zY8zbrn4B3-7n7Y</recordid><startdate>200401</startdate><enddate>200401</enddate><creator>Aronson, D.</creator><creator>Bartha, P.</creator><creator>Zinder, O.</creator><creator>Kerner, A.</creator><creator>Shitman, E.</creator><creator>Markiewicz, W.</creator><creator>Brook, G. J.</creator><creator>Levy, Y.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200401</creationdate><title>Association between fasting glucose and C-reactive protein in middle-aged subjects</title><author>Aronson, D. ; Bartha, P. ; Zinder, O. ; Kerner, A. ; Shitman, E. ; Markiewicz, W. ; Brook, G. J. ; Levy, Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Blood Glucose - analysis</topic><topic>Body Mass Index</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - analysis</topic><topic>Cholesterol, HDL - blood</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Fasting - blood</topic><topic>Female</topic><topic>glucose</topic><topic>Hormone Replacement Therapy</topic><topic>Humans</topic><topic>inflammation</topic><topic>insulin resistance syndrome</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Syndrome - blood</topic><topic>Middle Aged</topic><topic>obesity</topic><topic>Smoking</topic><topic>Uric Acid - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aronson, D.</creatorcontrib><creatorcontrib>Bartha, P.</creatorcontrib><creatorcontrib>Zinder, O.</creatorcontrib><creatorcontrib>Kerner, A.</creatorcontrib><creatorcontrib>Shitman, E.</creatorcontrib><creatorcontrib>Markiewicz, W.</creatorcontrib><creatorcontrib>Brook, G. J.</creatorcontrib><creatorcontrib>Levy, Y.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aronson, D.</au><au>Bartha, P.</au><au>Zinder, O.</au><au>Kerner, A.</au><au>Shitman, E.</au><au>Markiewicz, W.</au><au>Brook, G. J.</au><au>Levy, Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between fasting glucose and C-reactive protein in middle-aged subjects</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2004-01</date><risdate>2004</risdate><volume>21</volume><issue>1</issue><spage>39</spage><epage>44</epage><pages>39-44</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><coden>DIMEEV</coden><abstract>Aims  C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects. Methods  We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years). Results  Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend &lt; 0.0001). Increasing CRP with higher fasting glucose levels was apparent even among subjects with fasting glucose in the normal range (Ptrend = 0.039), and subjects with fasting glucose level in the upper quartile of normal fasting glucose had higher CRP levels compared with subjects in the lower quartile (P = 0.035). There was a positive crude correlation between CRP and smoking, post‐menopausal hormone use, body mass index, fasting glucose, triglycerides, hypertension, and uric acid (r = 0.11–0.36, P = 0.002–0.0001). A negative correlation was found between CRP and HDL‐cholesterol (r = 0.12, P &lt; 0.0001) and physical activity (r = 0.11, P = 0.002). After adjustment for potential confounders in a stepwise multivariate linear regression model, fasting glucose remained significantly and independently related to CRP levels (correlation coefficient 0.06; 95% confidence interval 0.014–0.11, P = 0.011). Conclusions  Fasting glucose is significantly and positively associated with plasma CRP in middle‐aged subjects. CRP levels increase continuously across the spectrum of fasting glucose, beginning in the lowest quartile of normal fasting glucose. This finding suggests that a proinflammatory effect may contribute to the adverse cardiovascular outcome associated with diabetes, impaired fasting glucose, and increasing glucose levels within the normal range.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>14706052</pmid><doi>10.1046/j.1464-5491.2003.01084.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0742-3071
ispartof Diabetic medicine, 2004-01, Vol.21 (1), p.39-44
issn 0742-3071
1464-5491
language eng
recordid cdi_proquest_miscellaneous_80083950
source Wiley-Blackwell Read & Publish Collection
subjects Biological and medical sciences
Blood Glucose - analysis
Body Mass Index
C-reactive protein
C-Reactive Protein - analysis
Cholesterol, HDL - blood
Cross-Sectional Studies
Diabetes Mellitus - blood
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Fasting - blood
Female
glucose
Hormone Replacement Therapy
Humans
inflammation
insulin resistance syndrome
Male
Medical sciences
Metabolic Syndrome - blood
Middle Aged
obesity
Smoking
Uric Acid - blood
title Association between fasting glucose and C-reactive protein in middle-aged subjects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A18%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20fasting%20glucose%20and%20C-reactive%20protein%20in%20middle-aged%20subjects&rft.jtitle=Diabetic%20medicine&rft.au=Aronson,%20D.&rft.date=2004-01&rft.volume=21&rft.issue=1&rft.spage=39&rft.epage=44&rft.pages=39-44&rft.issn=0742-3071&rft.eissn=1464-5491&rft.coden=DIMEEV&rft_id=info:doi/10.1046/j.1464-5491.2003.01084.x&rft_dat=%3Cproquest_cross%3E80083950%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4994-1bf9f5e5f619fbe8b876a0934e2a49cc3e813d36f074c31cbe8265ea2e9899563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80083950&rft_id=info:pmid/14706052&rfr_iscdi=true